Celldex Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Celldex Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $907k | 22k | 41.98 |
| 2023-12-31 | $585k | 15k | 39.66 |
| 2023-09-30 | $1.2M | 42k | 27.52 |
| 2023-06-30 | $1.8M | 54k | 33.93 |
| 2022-12-31 | $47k | 1.0k | 44.57 |
| 2022-09-30 | $74k | 2.6k | 28.78 |
| 2022-06-30 | $61k | 2.8k | 21.74 |
| 2022-03-31 | $1.1M | 33k | 34.05 |
| 2021-12-31 | $1.9M | 47k | 39.71 |
| 2021-09-30 | $1.0M | 20k | 50.00 |
| 2021-06-30 | $5.1k | 149 | 34.48 |
| 2021-03-31 | $3.7k | 169 | 21.98 |
| 2020-12-31 | $867k | 50k | 17.52 |
| 2020-09-30 | $6.4k | 382 | 16.67 |
| 2020-06-30 | $2.3k | 251 | 9.17 |
| 2020-03-31 | $0 | 330 | 0.00 |
| 2019-12-31 | $0 | 305 | 0.00 |
| 2019-09-30 | $0 | 225 | 0.00 |
| 2019-06-30 | $1.3k | 573 | 2.32 |
| 2019-03-31 | $2.0k | 481 | 4.16 |